Symptoms, Triggers, and the Right Way to Test for Mast Cell Activation - Body of Harmony

Symptoms, Triggers, and the Right Way to Test for Mast Cell Activation

by: Payam Hakimi
October 2026
0 comments

Medically reviewed by Payam Hakimi, D.O., Medical Director, Body of Harmony Institute of Health & Healing

Why might one person experience flushing, digestive problems, headaches, brain fog, a racing heart, nasal congestion, itching, and food reactions — often in unexplained episodes with no obvious common cause?

One possible explanation is abnormal activation of mast cells.

Mast Cell Activation Syndrome (MCAS) has received growing attention in both conventional and integrative medicine, because mast cells can influence many organ systems at once. At the same time, MCAS is frequently misunderstood and overdiagnosed.

The essential distinction is this: having symptoms that can occur with mast-cell activation does not, by itself, establish a diagnosis of MCAS. A proper evaluation looks for a characteristic pattern of recurrent symptoms, objective laboratory evidence of mast-cell mediator release, and an appropriate response to treatment directed at those mediators.

What Are Mast Cells?

Mast cells are specialized immune cells found throughout the body, especially where tissues meet the outside environment. They are abundant in:

Skin
Respiratory tract
Gastrointestinal tract
Blood vessels
Connective tissue
Tissue surrounding nerves and other organs

Mast cells are part of the body's defense system. When appropriately activated, they release chemical mediators — including histamine, tryptase, prostaglandins, leukotrienes, and inflammatory signaling molecules. These substances act on blood vessels, nerves, smooth muscle, the digestive tract, and the immune system.

Problems arise when mast-cell activation becomes excessive, inappropriate, or poorly regulated.

What Is Mast Cell Activation Syndrome?

MCAS is a clinical condition in which mast cells release mediators inappropriately, producing recurrent episodes of symptoms that involve more than one organ system.

Because mast cells are distributed throughout the body, the presentation varies widely. One person may primarily experience flushing and swelling. Another may have abdominal pain and diarrhea. Someone else may experience palpitations, lightheadedness, or episodes resembling an allergic reaction. This variability is one reason MCAS can be difficult to recognize.

Symptoms and Signs of MCAS

Mast-cell mediator release can affect virtually every organ system. The symptoms below are listed by system. Many are nonspecific on their own; their significance increases when they occur together in recurrent, recognizable episodes.

Skin

Flushing or a sudden sensation of heat
Itching
Hives (urticaria)
Dermatographism (raised marks after the skin is stroked or scratched)
Angioedema — swelling of the lips, eyelids, or face
Burning or tingling sensations of the skin
Unexplained rashes
Heat sensitivity, or symptoms triggered by friction or pressure

Isolated chronic hives or dermatographism, without involvement of other organ systems, is usually chronic spontaneous urticaria rather than MCAS. Dermatographism is also common in the general population.

Gastrointestinal

Mast cells are abundant throughout the digestive tract, so digestive symptoms are common:

Abdominal pain or cramping
Bloating and abdominal distension
Nausea or vomiting
Diarrhea or bowel urgency
Changes in intestinal motility
Reflux or heartburn
Food-associated digestive symptoms

Digestive symptoms alone do not establish MCAS. Irritable bowel syndrome (IBS), inflammatory bowel disease, celiac disease, food allergy, small intestinal bacterial overgrowth (SIBO), and infections can all produce similar symptoms.

Cardiovascular

Rapid heart rate or palpitations
Low or fluctuating blood pressure
Lightheadedness or dizziness
Near-fainting (presyncope) or fainting (syncope)

Severe mast-cell reactions can progress to anaphylaxis, which is a medical emergency.

Respiratory and Ear, Nose, and Throat

Nasal congestion, runny nose, sneezing, or nasal itching
Postnasal drainage
Throat tightness or hoarseness
Wheezing, cough, or chest tightness
Shortness of breath or a sensation of airway narrowing

These symptoms can resemble asthma or allergic rhinitis.

Neurologic

Headaches or migraines
Brain fog, difficulty concentrating, or cognitive slowing
Fatigue
Tingling or abnormal sensations

These symptoms occur with many conditions. They become more meaningful when they appear as part of a reproducible, multisystem pattern.

Genitourinary and Hormonal

Urinary urgency or frequency
Bladder or pelvic discomfort
Symptom flares around menstruation or other hormonal transitions
Vulvar or vaginal itching or irritation

Musculoskeletal and Systemic

Muscle aches or joint discomfort
Generalized body discomfort or malaise
Exercise intolerance
Temperature dysregulation

The genitourinary, hormonal, musculoskeletal, and systemic symptoms are the least specific for MCAS. They should be interpreted only within the full clinical picture and never attributed to mast cells without appropriate evaluation.

Common Triggers of Mast-Cell Symptoms

An important clinical clue is whether symptoms recur after specific exposures. Reported triggers include:

Trigger	Examples
Foods	Specific foods in susceptible individuals
Heat and temperature change	Hot weather, hot baths or showers, sudden temperature shifts
Exercise	Physical exertion
Stress	Emotional or physiological stress
Medications	Certain NSAIDs, opioids, some antibiotics such as vancomycin, radiocontrast media, and certain anesthetic agents
Alcohol	Flushing and other symptoms after drinking
Environmental exposures	Pollen, mold, dust, fragrances, smoke
Hormonal changes	Menstruation and other hormonal transitions
Physical stimulation	Pressure, friction, or scratching of the skin

Patients with a history of mast-cell reactions who are scheduled for surgery, imaging with contrast, or other procedures should inform their care team in advance, so that appropriate precautions can be planned.

The key clinical question is not simply, "Do you have these symptoms?" It is: "Do your symptoms occur in a recurrent, recognizable pattern involving more than one organ system?"

How Is MCAS Diagnosed?

MCAS should not be diagnosed simply because someone has food sensitivities, brain fog, fatigue, bloating, headaches, histamine intolerance, IBS, anxiety-like episodes, or flushing. Each of these has many possible causes.

Diagnostic criteria for MCAS remain an area of active debate. Some clinicians apply broad criteria based largely on chronic symptoms. This article follows the stricter international consensus criteria developed by mast-cell experts (European Competence Network on Mastocytosis and the American Academy of Allergy, Asthma & Immunology), which require all three of the following:

Compatible recurrent symptoms. Episodes consistent with mast-cell mediator release, typically severe or anaphylaxis-like and involving at least two organ systems at the same time.
Objective evidence of mediator release. Laboratory confirmation that mast-cell mediators rise during symptomatic episodes — most specifically, an acute increase in serum tryptase.
Response to mast-cell–directed therapy. Symptoms improve with medications that block or stabilize mast-cell mediators. Examples include H1 and H2 antihistamines, cromolyn sodium, leukotriene-modifying agents, and, in selected patients, omalizumab.

Response to therapy supports the diagnosis but is never sufficient on its own. Symptoms alone are not enough.

Blood and Urine Testing for MCAS

The right tests, collected at the right time, matter more than the number of tests ordered. Testing should be guided by the clinical presentation and timed to capture mediator release.

Serum Tryptase

Serum tryptase is the most important and most specific laboratory test for mast-cell activation. Ideally, two measurements are compared:

Acute tryptase — drawn during or soon after a significant episode, ideally within 30 minutes to 2 hours of symptom onset and no later than about 4 hours. Tryptase typically peaks 1 to 2 hours after an episode begins.
Baseline tryptase — drawn when the patient feels well, at least 24 to 48 hours after symptoms have fully resolved.

For example, if baseline tryptase is 5 ng/mL, an acute value of 8 ng/mL or higher meets the criterion. A qualifying rise counts even when both values fall within the laboratory's normal reference range. A normal baseline tryptase therefore does not exclude mast-cell activation.

Urine Mast-Cell Mediator Testing

Three urinary markers reflect different mediator pathways and together provide a broader picture than any single test:

Test	Pathway it reflects
Urine N-methylhistamine	Histamine
Urine 2,3-dinor-11β-prostaglandin F2α	Prostaglandin D2
Urine leukotriene E4	Leukotrienes

Collection technique strongly affects these results:

Timing: collect during or within a few hours of an episode, as a spot urine or a 24-hour collection.
Handling: keep samples refrigerated; the prostaglandin and leukotriene metabolites degrade at room temperature.
Medications: aspirin and other NSAIDs suppress 2,3-dinor-11β-PGF2α and can produce false-negative results. Leukotriene modifiers such as montelukast and zileuton can affect leukotriene E4.

Diagnostic thresholds for the urine markers are less standardized than the tryptase criterion. An acute tryptase rise remains the most specific evidence of mast-cell activation.

A Practical MCAS Laboratory Evaluation

Depending on the clinical presentation, an initial evaluation may include:

Core mast-cell mediator testing

Serum tryptase — baseline
Serum tryptase — during or after an episode
Urine N-methylhistamine
Urine 2,3-dinor-11β-PGF2α
Urine leukotriene E4

General laboratory evaluation

CBC with differential
Comprehensive metabolic panel, including creatinine/eGFR, liver enzymes, and albumin
ESR and CRP
Total IgE, with specific IgE or allergist skin testing when food or environmental allergy is suspected

The general tests do not diagnose MCAS. They help identify other inflammatory, allergic, immune, metabolic, or systemic conditions that may contribute to symptoms. Kidney function is especially relevant, because impaired kidney function can raise baseline tryptase.

What If Baseline Tryptase Is Elevated?

A persistently elevated baseline tryptase deserves further evaluation. Kidney impairment should be considered first, since it can raise tryptase on its own. Beyond that:

Above about 8 ng/mL: consider TPSAB1 copy-number testing for hereditary alpha-tryptasemia (HαT). HαT is a common inherited trait that raises baseline tryptase and is associated with a range of symptoms in some individuals.
Above 20 ng/mL: this is a minor diagnostic criterion for systemic mastocytosis, a clonal mast-cell disorder, and warrants further workup.
KIT D816V mutation testing: helps evaluate for a clonal mast-cell disorder. It should be performed on peripheral blood using a high-sensitivity method (digital droplet PCR or allele-specific quantitative PCR), because standard sequencing can miss the mutation.

When appropriate, patients may be referred to an allergist/immunologist or hematologist. In selected patients, bone marrow evaluation may be needed.

Other Conditions That Can Mimic MCAS

One of the most important principles in evaluating MCAS is to avoid prematurely attributing every unexplained symptom to mast-cell activation. Depending on the presentation, physicians may need to consider:

Food allergy
Chronic spontaneous urticaria
Histamine intolerance
IBS, inflammatory bowel disease, celiac disease, or SIBO
POTS and other forms of dysautonomia
Autoimmune disease
Thyroid disorders
Hereditary angioedema and other bradykinin-mediated angioedema
Pheochromocytoma
Carcinoid syndrome and other neuroendocrine disorders
Medication reactions
Other allergic and inflammatory conditions

Some patterns point toward specific alternative evaluations:

Recurrent swelling without hives may warrant testing for hereditary angioedema, including complement C4 and C1 esterase inhibitor level and function.
Flushing with episodic high blood pressure, sweating, and palpitations may require testing for catecholamine excess, such as plasma free metanephrines.
Flushing with diarrhea may warrant a 24-hour urine 5-HIAA to evaluate for carcinoid syndrome.

The goal is not simply to find a label. It is to understand why the patient is experiencing these symptoms.

What About Histamine and DAO Testing?

Commercially marketed "histamine intolerance" testing causes considerable confusion.

A serum or plasma histamine level is not a reliable standalone test for MCAS; histamine is cleared within minutes and is easily affected by sample handling. Serum diamine oxidase (DAO) testing is sometimes marketed to diagnose histamine intolerance, but it is not a diagnostic test for MCAS.

The same principle applies to many commercial "mast-cell panels." More testing does not mean better diagnosis.

The Functional Medicine Perspective

A thoughtful evaluation asks more than whether a patient meets criteria. It asks:

What triggers the symptoms, and how reproducible are the episodes?
How many organ systems are involved?
Is there objective evidence of mast-cell mediator release?
Could another condition better explain the symptoms?
Is there evidence of a clonal or secondary cause?

From a functional medicine perspective, it is also useful to look at the broader context:

Gastrointestinal or microbiome-related issues
Nutritional deficiencies
Chronic inflammation
Environmental exposures
Medications that may contribute to symptoms
Hormonal fluctuations associated with flares
Autonomic dysfunction
Underlying allergic or immune conditions
Sleep, stress, and lifestyle factors

This does not mean every underlying problem is caused by MCAS. The goal is to understand the individual patient as a whole and identify which factors contribute to mast-cell activation and overall symptom burden.

When Should You Seek Medical Evaluation?

Medical evaluation is especially important when symptoms are:

Recurrent and unexplained
Triggered by multiple different exposures
Involving several organ systems
Associated with hives or swelling
Associated with significant changes in blood pressure
Associated with fainting or near-fainting
Associated with breathing difficulty
Associated with recurrent severe allergic-type reactions

Difficulty breathing, throat swelling, severe dizziness, loss of consciousness, or other signs of anaphylaxis require emergency care — call 911. Patients with a history of anaphylaxis should carry an epinephrine auto-injector as prescribed and use it without delay.

The Bottom Line

Mast cells are an important part of the immune system, but inappropriate mast-cell activation can produce symptoms throughout the body — skin, digestive, cardiovascular, respiratory, and neurologic. That breadth is one reason MCAS can be difficult to recognize, and also one reason it is easy to overdiagnose.

A careful evaluation combines:

Compatible, recurrent multisystem symptoms
Objective evidence of mast-cell mediator release, collected at the right time
An appropriate response to mast-cell–directed therapy
Evaluation for alternative and underlying causes

At Body of Harmony, we believe that understanding the patient requires looking beyond a single symptom or diagnosis. Our goal is to identify patterns, investigate contributing factors, and develop an individualized approach grounded in the patient's full clinical picture.

If you are experiencing recurrent, unexplained symptoms affecting several body systems, schedule a consultation with Body of Harmony in Beverly Hills or Miami at bodyofharmony.com.

Frequently Asked Questions

What is Mast Cell Activation Syndrome (MCAS)?

MCAS is a condition in which mast cells inappropriately release chemical mediators such as histamine, tryptase, prostaglandins, and leukotrienes. This causes recurrent episodes of symptoms involving two or more organ systems, such as the skin, digestive tract, heart and blood vessels, and airways.

What are the most common symptoms of MCAS?

Common symptoms include flushing, itching, hives, swelling, abdominal pain, diarrhea, rapid heart rate, lightheadedness, nasal congestion, and wheezing. These symptoms are nonspecific on their own; they suggest MCAS mainly when they recur together in recognizable episodes.

How is MCAS diagnosed?

Under international consensus criteria, diagnosis requires three elements: recurrent episodes of symptoms involving at least two organ systems, objective laboratory evidence of mast-cell mediator release, and improvement with mast-cell–directed therapy. Symptoms alone are not enough.

When should a tryptase test be drawn for MCAS?

An acute tryptase should be drawn ideally within 30 minutes to 2 hours of symptom onset, and no later than about 4 hours. It is compared with a baseline tryptase drawn at least 24 to 48 hours after symptoms resolve. A rise of 20 percent plus 2 ng/mL above baseline supports mast-cell activation.

Does a normal tryptase level rule out MCAS?

No. A normal baseline tryptase does not exclude MCAS. A qualifying acute rise above the patient's own baseline is meaningful even when both values fall within the laboratory's normal range.

Are histamine or DAO blood tests useful for diagnosing MCAS?

No. Serum histamine is not a reliable standalone test for MCAS, and diamine oxidase (DAO) testing is not a diagnostic test for MCAS. Properly timed tryptase and urine mediator testing are more informative.

Important Medical Disclaimer

This article is intended for educational purposes only and is not a substitute for individualized medical evaluation, diagnosis, or treatment. MCAS can overlap with a number of allergic, immune, gastrointestinal, cardiovascular, neurologic, and endocrine conditions. Laboratory testing should be ordered and interpreted by a qualified healthcare professional. Anyone experiencing symptoms of a severe allergic reaction or anaphylaxis should seek emergency medical care immediately.

References

Valent P, Akin C, Arock M, et al. Definitions, criteria and global classification of mast cell disorders with special reference to mast cell activation syndromes: a consensus proposal. Int Arch Allergy Immunol. 2012;157(3):215–225.
Valent P, Akin C, Bonadonna P, et al. Proposed diagnostic algorithm for patients with suspected mast cell activation syndrome. J Allergy Clin Immunol Pract. 2019;7(4):1125–1133.
Weiler CR, Austen KF, Akin C, et al. AAAAI Mast Cell Disorders Committee Work Group Report: Mast cell activation syndrome (MCAS) diagnosis and management. J Allergy Clin Immunol. 2019;144(4):883–896.
Lyons JJ, Yu X, Hughes JD, et al. Elevated basal serum tryptase identifies a multisystem disorder associated with increased TPSAB1 copy number. Nat Genet. 2016;48(12):1564–1569.

Disclaimer: These statements have not been evaluated by the Food and Drug Administration (FDA). This Information / product is not intended to diagnose, treat, cure, or prevent any disease. Always consult with your physician or qualified healthcare provider before starting any new dietary supplement, especially if you are pregnant, nursing, taking medications, or have a medical condition. Discontinue use and consult a healthcare professional if any adverse reactions occur.

This article is for educational purposes and is not a substitute for professional medical advice. Talk to a qualified healthcare professional about your test results and any symptoms you're experiencing.

By purchasing or using this product, you acknowledge and accept full responsibility for your own health decisions and agree to hold the manufacturer, distributor, and affiliated parties harmless against any and all liability, loss, or damage resulting from use or misuse of this product.

Prev Post

Best Ways to Increase Ferritin Levels

Next Post

TMAO: The Gut-Heart Connection Your Cardiologist May Not Be Measuring

Post Comment

Recently Bought

5 seconds ago

View Product →